Palliative radiofrequency ablation for recurrent prostate cancer

Percutaneous radiofrequency ablation (RFA) is a minimally invasive local therapy for cancer. Its efficacy is now becoming well documented in many different organs, including liver, kidney, and lung. The goal of RFA is typically complete eradication of a tumor in lieu of an invasive surgical procedur...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular and interventional radiology 2006-06, Vol.29 (3), p.482-485
Main Authors: Jindal, Gaurav, Friedman, Marc, Locklin, Julia, Wood, Bradford J
Format: Article
Language:English
Subjects:
ABLATION
Aged
Catheter Ablation
Humans
KIDNEYS
LIVER
LUNGS
Male
METASTASES
Neoplasm Recurrence, Local
NEOPLASMS
PAIN
Pain management
Pain Measurement
Palliative Care - methods
PATIENTS
PROSTATE
Prostate cancer
Prostatic Neoplasms - diagnostic imaging
Prostatic Neoplasms - pathology
Prostatic Neoplasms - surgery
RADIOLOGY AND NUCLEAR MEDICINE
RADIOWAVE RADIATION
SURGERY
THERAPY
Tomography, X-Ray Computed
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Percutaneous radiofrequency ablation (RFA) is a minimally invasive local therapy for cancer. Its efficacy is now becoming well documented in many different organs, including liver, kidney, and lung. The goal of RFA is typically complete eradication of a tumor in lieu of an invasive surgical procedure. However, RFA can also play an important role in the palliative care of cancer patients. Tumors which are surgically unresectable and incompatible for complete ablation present the opportunity for RFA to be used in a new paradigm. Cancer pain runs the gamut from minor discomfort relieved with mild pain medication to unrelenting suffering for the patient, poorly controlled by conventional means. RFA is a tool which can potentially palliate intractable cancer pain. We present here a case in which RFA provided pain relief in a patient with metastatic prostate cancer with pain uncontrolled by conventional methods.
ISSN:0174-1551
1432-086X
DOI:10.1007/s00270-004-0200-8